mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.7 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
-0.053 |
0.7 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |